Concepts (157)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Narcolepsy | 16 | 2022 | 45 | 5.280 |
Why?
|
Sodium Oxybate | 9 | 2022 | 13 | 4.430 |
Why?
|
Disorders of Excessive Somnolence | 11 | 2022 | 28 | 4.140 |
Why?
|
Restless Legs Syndrome | 11 | 2018 | 18 | 3.320 |
Why?
|
Polysomnography | 14 | 2022 | 92 | 3.010 |
Why?
|
Sleep Apnea, Obstructive | 7 | 2022 | 142 | 2.180 |
Why?
|
Cataplexy | 7 | 2022 | 25 | 2.000 |
Why?
|
Dopamine Agonists | 7 | 2017 | 68 | 1.840 |
Why?
|
Carbamates | 5 | 2020 | 41 | 1.800 |
Why?
|
Phenylalanine | 3 | 2020 | 22 | 1.380 |
Why?
|
Sleep, REM | 5 | 2018 | 93 | 1.310 |
Why?
|
Tetrahydronaphthalenes | 3 | 2017 | 20 | 1.160 |
Why?
|
Indoles | 4 | 2017 | 146 | 1.140 |
Why?
|
Double-Blind Method | 14 | 2022 | 1738 | 0.850 |
Why?
|
Adult | 31 | 2022 | 21403 | 0.850 |
Why?
|
gamma-Aminobutyric Acid | 3 | 2015 | 208 | 0.830 |
Why?
|
Hypnotics and Sedatives | 3 | 2015 | 96 | 0.810 |
Why?
|
Benzhydryl Compounds | 5 | 2016 | 62 | 0.760 |
Why?
|
Wakefulness | 8 | 2017 | 75 | 0.690 |
Why?
|
Middle Aged | 27 | 2022 | 21147 | 0.670 |
Why?
|
Sleep Wake Disorders | 3 | 2016 | 94 | 0.670 |
Why?
|
Sleep Latency | 1 | 2018 | 1 | 0.660 |
Why?
|
Treatment Outcome | 16 | 2022 | 7029 | 0.640 |
Why?
|
Methylphenidate | 1 | 2019 | 97 | 0.630 |
Why?
|
Aged | 22 | 2022 | 14862 | 0.620 |
Why?
|
Sleep | 7 | 2022 | 263 | 0.610 |
Why?
|
Benzothiazoles | 1 | 2017 | 14 | 0.600 |
Why?
|
Humans | 44 | 2022 | 68618 | 0.590 |
Why?
|
Quality of Life | 5 | 2020 | 1515 | 0.580 |
Why?
|
Male | 31 | 2022 | 37321 | 0.560 |
Why?
|
Female | 31 | 2022 | 38074 | 0.550 |
Why?
|
Ligands | 1 | 2017 | 317 | 0.550 |
Why?
|
Home Care Services | 1 | 2017 | 84 | 0.540 |
Why?
|
Thiophenes | 2 | 2014 | 76 | 0.540 |
Why?
|
Disease Susceptibility | 1 | 2017 | 179 | 0.530 |
Why?
|
Young Adult | 10 | 2022 | 5717 | 0.490 |
Why?
|
Monitoring, Ambulatory | 1 | 2014 | 84 | 0.460 |
Why?
|
Mood Disorders | 1 | 2015 | 132 | 0.460 |
Why?
|
Monitoring, Physiologic | 1 | 2014 | 219 | 0.450 |
Why?
|
Photoplethysmography | 1 | 2013 | 15 | 0.440 |
Why?
|
Oximetry | 1 | 2013 | 29 | 0.430 |
Why?
|
Cross-Over Studies | 6 | 2022 | 260 | 0.420 |
Why?
|
Central Nervous System Stimulants | 4 | 2012 | 221 | 0.410 |
Why?
|
Signal Processing, Computer-Assisted | 1 | 2013 | 100 | 0.410 |
Why?
|
Adolescent | 10 | 2022 | 8912 | 0.400 |
Why?
|
Sleep Deprivation | 4 | 2012 | 81 | 0.400 |
Why?
|
Pain | 1 | 2015 | 472 | 0.390 |
Why?
|
Aged, 80 and over | 6 | 2018 | 4848 | 0.350 |
Why?
|
Glucose Intolerance | 1 | 2010 | 36 | 0.350 |
Why?
|
Veterans | 1 | 2017 | 904 | 0.340 |
Why?
|
Dose-Response Relationship, Drug | 7 | 2015 | 1745 | 0.300 |
Why?
|
Sleep Initiation and Maintenance Disorders | 1 | 2008 | 91 | 0.290 |
Why?
|
Pyridines | 1 | 2008 | 261 | 0.280 |
Why?
|
Weight Loss | 1 | 2008 | 319 | 0.270 |
Why?
|
Neoplasm, Residual | 1 | 2005 | 33 | 0.250 |
Why?
|
Retrospective Studies | 6 | 2017 | 7277 | 0.240 |
Why?
|
United States | 6 | 2019 | 7367 | 0.210 |
Why?
|
Biological Availability | 1 | 2022 | 79 | 0.210 |
Why?
|
Healthy Volunteers | 1 | 2022 | 78 | 0.210 |
Why?
|
Surveys and Questionnaires | 3 | 2020 | 2800 | 0.200 |
Why?
|
Neuroprotective Agents | 1 | 2005 | 317 | 0.200 |
Why?
|
Comorbidity | 2 | 2017 | 1426 | 0.190 |
Why?
|
Child, Preschool | 2 | 2018 | 3187 | 0.190 |
Why?
|
Potassium | 1 | 2021 | 168 | 0.180 |
Why?
|
Sodium | 1 | 2021 | 161 | 0.180 |
Why?
|
Magnesium | 1 | 2021 | 110 | 0.180 |
Why?
|
Wakefulness-Promoting Agents | 2 | 2017 | 6 | 0.180 |
Why?
|
Proteomics | 1 | 2022 | 246 | 0.180 |
Why?
|
Sensitivity and Specificity | 2 | 2015 | 1753 | 0.180 |
Why?
|
Drug Administration Schedule | 4 | 2010 | 567 | 0.160 |
Why?
|
Diagnostic Self Evaluation | 1 | 2018 | 18 | 0.160 |
Why?
|
International Cooperation | 1 | 2018 | 88 | 0.160 |
Why?
|
Severity of Illness Index | 4 | 2018 | 1851 | 0.150 |
Why?
|
Prevalence | 3 | 2018 | 1619 | 0.150 |
Why?
|
Calcium | 1 | 2021 | 929 | 0.140 |
Why?
|
Transdermal Patch | 2 | 2014 | 21 | 0.140 |
Why?
|
Adjuvants, Anesthesia | 1 | 2016 | 8 | 0.140 |
Why?
|
Child | 2 | 2018 | 6405 | 0.140 |
Why?
|
Reproducibility of Results | 2 | 2018 | 2077 | 0.140 |
Why?
|
Family | 1 | 2018 | 293 | 0.140 |
Why?
|
Veterans Health | 1 | 2016 | 62 | 0.130 |
Why?
|
Risk | 1 | 2017 | 563 | 0.130 |
Why?
|
Sleep Disorders, Circadian Rhythm | 2 | 2012 | 5 | 0.120 |
Why?
|
PubMed | 1 | 2014 | 21 | 0.120 |
Why?
|
Administration, Oral | 1 | 2015 | 411 | 0.120 |
Why?
|
Administration, Cutaneous | 1 | 2014 | 56 | 0.120 |
Why?
|
Video Recording | 1 | 2014 | 145 | 0.110 |
Why?
|
Palate, Soft | 1 | 2013 | 12 | 0.110 |
Why?
|
Tongue | 1 | 2013 | 20 | 0.110 |
Why?
|
United States Food and Drug Administration | 1 | 2014 | 131 | 0.110 |
Why?
|
Point-of-Care Systems | 1 | 2014 | 115 | 0.110 |
Why?
|
Cross-Sectional Studies | 3 | 2016 | 2279 | 0.110 |
Why?
|
Equipment Design | 1 | 2014 | 500 | 0.110 |
Why?
|
Sleep Apnea Syndromes | 1 | 2013 | 40 | 0.110 |
Why?
|
Lung Diseases | 1 | 2014 | 175 | 0.110 |
Why?
|
Odds Ratio | 1 | 2014 | 880 | 0.100 |
Why?
|
Time Factors | 3 | 2017 | 4655 | 0.100 |
Why?
|
Drug Delivery Systems | 1 | 2014 | 236 | 0.100 |
Why?
|
Multivariate Analysis | 1 | 2014 | 1046 | 0.100 |
Why?
|
Sex Factors | 1 | 2014 | 1266 | 0.090 |
Why?
|
Logistic Models | 1 | 2014 | 1420 | 0.090 |
Why?
|
Predictive Value of Tests | 1 | 2014 | 1465 | 0.090 |
Why?
|
Patient Compliance | 1 | 2013 | 402 | 0.090 |
Why?
|
Jet Lag Syndrome | 1 | 2010 | 3 | 0.090 |
Why?
|
Ambulatory Care | 1 | 2013 | 340 | 0.090 |
Why?
|
Drug Tolerance | 1 | 2010 | 80 | 0.090 |
Why?
|
Bed Rest | 1 | 2009 | 17 | 0.090 |
Why?
|
Age Factors | 1 | 2014 | 1864 | 0.090 |
Why?
|
Diagnosis, Differential | 1 | 2013 | 1140 | 0.090 |
Why?
|
Mass Screening | 2 | 2013 | 843 | 0.080 |
Why?
|
GABA-A Receptor Antagonists | 1 | 2008 | 7 | 0.080 |
Why?
|
Half-Life | 1 | 2008 | 96 | 0.080 |
Why?
|
Glucose Tolerance Test | 1 | 2008 | 75 | 0.080 |
Why?
|
Delayed-Action Preparations | 1 | 2008 | 120 | 0.080 |
Why?
|
Receptors, GABA-A | 1 | 2008 | 89 | 0.080 |
Why?
|
Circadian Rhythm | 2 | 2012 | 218 | 0.080 |
Why?
|
Benzodiazepines | 1 | 2008 | 130 | 0.070 |
Why?
|
Obesity | 1 | 2014 | 1076 | 0.070 |
Why?
|
Blood Glucose | 1 | 2010 | 631 | 0.070 |
Why?
|
Continuous Positive Airway Pressure | 2 | 2022 | 33 | 0.070 |
Why?
|
Risk Factors | 2 | 2014 | 5731 | 0.070 |
Why?
|
Hypertension | 1 | 2014 | 1535 | 0.060 |
Why?
|
Evidence-Based Medicine | 1 | 2008 | 438 | 0.060 |
Why?
|
Nocturnal Myoclonus Syndrome | 1 | 2004 | 3 | 0.060 |
Why?
|
Motor Activity | 1 | 2008 | 621 | 0.060 |
Why?
|
Antiparkinson Agents | 1 | 2004 | 34 | 0.060 |
Why?
|
Reaction Time | 1 | 2005 | 170 | 0.060 |
Why?
|
Demography | 1 | 2005 | 279 | 0.060 |
Why?
|
Follow-Up Studies | 2 | 2009 | 3259 | 0.050 |
Why?
|
Sleep Stages | 1 | 2022 | 30 | 0.050 |
Why?
|
Stroke | 1 | 2014 | 2163 | 0.050 |
Why?
|
Hallucinations | 1 | 2018 | 19 | 0.040 |
Why?
|
Interviews as Topic | 1 | 2018 | 392 | 0.040 |
Why?
|
Biomarkers | 1 | 2022 | 1593 | 0.030 |
Why?
|
Health Behavior | 2 | 2012 | 458 | 0.030 |
Why?
|
Psychometrics | 1 | 2018 | 514 | 0.030 |
Why?
|
Longitudinal Studies | 1 | 2018 | 1054 | 0.030 |
Why?
|
Analysis of Variance | 2 | 2010 | 1040 | 0.030 |
Why?
|
Drug Therapy, Combination | 1 | 2016 | 649 | 0.030 |
Why?
|
Incidence | 1 | 2018 | 1603 | 0.030 |
Why?
|
Vacuum | 1 | 2013 | 14 | 0.030 |
Why?
|
Pressure | 1 | 2013 | 252 | 0.030 |
Why?
|
Animals | 1 | 2010 | 20881 | 0.030 |
Why?
|
Occupational Health | 1 | 2012 | 41 | 0.030 |
Why?
|
Caffeine | 1 | 2012 | 81 | 0.020 |
Why?
|
Homeostasis | 1 | 2012 | 291 | 0.020 |
Why?
|
Actigraphy | 1 | 2009 | 28 | 0.020 |
Why?
|
Patient Education as Topic | 1 | 2012 | 425 | 0.020 |
Why?
|
Psychomotor Performance | 1 | 2009 | 213 | 0.020 |
Why?
|
Randomized Controlled Trials as Topic | 1 | 2012 | 931 | 0.020 |
Why?
|
Neuropsychological Tests | 1 | 2009 | 517 | 0.020 |
Why?
|
Attitude to Health | 1 | 2010 | 403 | 0.020 |
Why?
|
Phototherapy | 1 | 2007 | 28 | 0.020 |
Why?
|
Causality | 1 | 2007 | 82 | 0.020 |
Why?
|
Prospective Studies | 1 | 2013 | 3705 | 0.020 |
Why?
|
Body Mass Index | 1 | 2008 | 867 | 0.020 |
Why?
|
Single-Blind Method | 1 | 2003 | 249 | 0.010 |
Why?
|